Journals / Klinik Psikofarmakoloji Bülteni / 2014 / Cilt: 24 - Sayı: 2

Dimenhidrinat bağımlılığı gelişen bir hasta: Olgu sunumu

A patient with dimenhydrinate dependence: A case report

Pages
184–187
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In addition, dimenhydrinate dependence is discussed by the author in the context of this case.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Dimenhydrinate, an antihistamine that is used for motion sickness, vertigo and emesis, is abused by drug addicts and psychiatric patients.
📊
Key Findings & Data:The case of a 33 year- old female, who was advised to use dimenhydrinate 50 mg/day for emesis early in her second pregnancy by her primary care physician and who continued to use the drug for 12 years at a daily dose of 300 mg without a prescription, is presented here.
💡
Conclusion & Impact:In addition, dimenhydrinate dependence is discussed by the author in the context of this case.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Dimenhydrinate, an antihistamine that is used for motion sickness, vertigo and emesis, is abused by drug addicts and psychiatric patients. In the literature, there are case reports about the addictive potential of antihistamines. To our knowledge, in the Turkish literature there have been no previous case reports of dimenhydrinate dependence. The case of a 33 year- old female, who was advised to use dimenhydrinate 50 mg/day for emesis early in her second pregnancy by her primary care physician and who continued to use the drug for 12 years at a daily dose of 300 mg without a prescription, is presented here. In addition, dimenhydrinate dependence is discussed by the author in the context of this case.

Özet

Taşıt tutması, vertigo ve emezisde kullanılandimenhidrinat, madde bağımlıları ve psikiyatri hastalarıtarafından kötüye kullanımı olan bir antihistaminiktir. Antihistaminiklerin bağımlılık yapıcı potansiyelleri ileilgili literatürde olgu bildirimleri yer almaktadır. Türkiye literatürüne geçmiş, dimenhidrinat bağımlılığı olan birolgu bildiğimiz kadarıyla bulunmamaktadır. Buradaikinci bebeğine hamile olduğu ilk ay içinde emezis tedavisi için doktor tarafından önerilen dimenhidrinat 50 mg/gün tedavisini kontrolsüz bir şekilde kesintisiz12 sene boyunca doz artırarak kullanmayı sürdüren,en son 300 mg/gün dozunda kullanmakta olan 33 yaşında bir kadın olgu ve tedavi süreci sunulmaktadır. Ayrıca bu olgu bağlamında dimenhidrinat bağımlılığıtartışılmaktadır.

🔖

Cite This Article

KAYA, F. D. (2022). Dimenhidrinat bağımlılığı gelişen bir hasta: Olgu sunumu. Klinik Psikofarmakoloji Bülteni, Cilt: 24 - Sayı: 2, 184–187. https://ajindex.com/articles/574014

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Halpert AG, Olmstead MC, Beninger RJ. Mechanisms and abuse liability of the anti-histamine dimenhydrinate. Neurosci Biobehav Rev 2002
  2. [CrossRef] 2. Medline Plus. http://www.nlm.nih.gov/medlineplus/ druginfo/meds/a607046.html 3. Tanda G, Kopajtic TA, Katz JL. Cocaine-like neurochemical effects of antihistaminic medications. J Neurochem. 2008
  3. 106(1):147-57. [CrossRef] 4. Young GB, Boyd D, Kreeft J. Dimenhydrinate: evidence for dependence and tolerance. CMAJ 1988
  4. 138(5):437-8. 5. Craig DF, Mellor CS. Dimenhydrinate dependence and withdrawal. CMAJ 1990
  5. 142(9):970-3. 6. Feldman MD, Behar M. A case of massive diphenhydramine abuse and withdrawal from use of the drug. JAMA 1986
  6. 255(22):3119-20. [CrossRef] 7. Prost E, Millson RC. Clozapine treatment of dimenhydrinate abuse. Am J Psychiatry 2004
  7. 161(8):1500. [CrossRef] 8. Dinndorf PA, McCabe MA, Frierdich S. Risk of abuse of diphenhydramine in children and adolescents with chronic illnesses. J Pediatr 1998
  8. 133(2):293-5. [CrossRef] 9. Saatcioglu O, Evren C. A case of pheniramine dependence. Subst Abus 2005
  9. 26(1):45-7. [CrossRef] 10. Bilici R, Eksioglu S, Tufan E. Pheniramine Dependence: A Case Report. Poster Presentations. Klinik Psikofarmakoloji Bülteni- Bulletin of Clinical Psychopharmacology 2012
  10. 22(Suppl. 1):S147. 11. Ogel K, Evren C, Karadag F, Gurol DT. The development, validity, and reliability of the Addiction Profile Index (API). Turk Psikiyatri Derg 2012
  11. 23(4):263-75. 12. Suzer O. Suzer Pharmacology, İstanbul: Published by Klinisyen Tıp Kitabevleri
  12. p. 517. (Turkish) 13. Campbell VC, Kopajtic TA, Newman AH, Katz JL. Assessment of the influence of histaminergic actions on cocaine- like effects of 3alpha-diphenylmethoxytropane analogs. J Pharmacol Exp Ther 2005
  13. 315(2):631-40. [CrossRef] 14. Fischer BA, Boggs DL. The role of antihistaminic effects in the misuse of quetiapine: a case report and review of the literature. Neurosci Biobehav Rev 2010
  14. 34(4):555-8. [CrossRef] 15. Halpert AG, Olmstead MC, Beninger RJ. Dimenhydrinate produces a conditioned place preference in rats. Pharmacol Biochem Behav 2003
  15. 75(1):173-9. [CrossRef] 16. Wang Z, Woolverton WL. Self-administration of cocaine- antihistamine combinations: super-additive reinforcing effects. Eur J Pharmacol 2007
  16. 557(2-3):159-60. [CrossRef]